Next-Generation Sequencing market to double to $29.53B by 2030, led by Asia-Pacific growth and precision medicine demand

The global Next-Generation Sequencing (NGS) market is projected to grow from $14.94 billion in 2025 to $29.53 billion by 2030, at a CAGR of 14.6%. This growth is driven by expanding applications in oncology, infectious diseases, reproductive health, and personalized medicine, alongside improved bioinformatics tools. Consumables dominate the product segment, while academic and research institutes lead service demand. The Asia-Pacific region is expected to grow fastest due to large genomic projects and rising precision medicine needs, especially in Japan and China with aging populations and increasing genetic disease prevalence.